[O067-1] Is SES-CD a predicted factor of loss of response to infliximab in Crohn's disease patients?
○Yutaka Nagata, Yuta Fuyuno, Motohiro Esaki (Dept. of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)